Cost Effectiveness of Vericiguat in Patients With Heart Failure With Reduced Ejection Fraction: Results From the VICTORIA Trial

被引：0
|
作者：
Chew, Derek S. [1 ]
Cowper, Patricia A. [2 ]
Bigelow, Robert [2 ]
Li, Yanhong [2 ]
Anstrom, Kevin [3 ]
Davidson-Ray, Linda D. [3 ]
Hernandez, Adrian F. [3 ]
O'Connor, Christopher M. [4 ]
Armstrong, Paul [5 ]
Mark, Daniel B. [6 ]
机构：
[1] Univ Calgary, Dept Cardiac Sci, Calgary, AB, Canada
[2] Duke Univ, Duke Clin Res Inst, Durham, NC USA
[3] Duke Clin Res Inst, Durham, NC USA
[4] Inova Heart & Vasc Inst, Cardiol, Falls Church, VA USA
[5] Univ Alberta, Dept Cardiol, Edmonton, AB, Canada
[6] Duke Univ, Med Ctr, Div Cardiol, Durham, NC 27710 USA
来源：
CIRCULATION | 2021年 / 144卷 / 25期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
17182
引用
收藏
页码：E586 / E586
页数：1
相关论文
共 50 条
  • [21] Vericiguat in the management of heart failure with reduced ejection fraction
    Aziz, Haya
    Gouda, Pishoy
    Sharma, Abhinav
    [J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (04) : E65 - E66
  • [22] NT-PROBNP DURING SCREENING IN THE STUDY OF VERICIGUAT IN PARTICIPANTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION (VICTORIA) TRIAL: INSIGHTS INTO OUTCOMES AND VERICIGUAT
    Westerhout, Cynthia M.
    Zheng, Yinggan
    Lund, Lars
    Butler, Javed
    Troughton, Richard W.
    Emdin, Michele
    Lam, Carolyn S. P.
    Ponikowski, Piotr
    Blaustein, Robert
    O'Connor, Christopher M.
    Roessig, Lothar
    Voors, Adriaan
    Ezekowitz, Justin A.
    Armstrong, Paul Wayne
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 730 - 730
  • [23] Population pharmacokinetics and pharmacodynamics of vericiguat in heart failure patients with reduced ejection fraction
    Meyer, M.
    Ruehs, H.
    Klein, D.
    Frei, M.
    Garmann, D.
    Grevel, J.
    Austin, R.
    Becker, C.
    Roessig, L.
    Pieske, B.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 376 - 376
  • [24] Vericiguat in patients with coronary artery disease and heart failure with reduced ejection fraction
    Saldarriaga, Clara
    Atar, Dan
    Stebbins, Amanda
    Lewis, Basil S.
    Abidin, Imran Zainal
    Blaustein, Robert O.
    Butler, Javed
    Ezekowitz, Justin A.
    Hernandez, Adrian F.
    Lam, Carolyn S. P.
    O'Connor, Christopher M.
    Pieske, Burkert
    Ponikowski, Piotr
    Roessig, Lothar
    Voors, Adriaan A.
    Anstrom, Kevin J.
    Armstrong, Paul W.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (05) : 782 - 790
  • [25] CORONARY ARTERY DISEASE AND CARDIOVASCULAR OUTCOMES IN HEART FAILURE: INSIGHTS FROM THE VERICIGUAT GLOBAL STUDY IN SUBJECTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION (VICTORIA) TRIAL
    Armstrong, Paul Wayne
    Giraldo, Clara Ines Saldarriaga
    Atar, Dan
    Stebbins, Amanda
    Lewis, Basil
    Abidin, Imran
    Butler, Javed
    Ezekowitz, Justin
    Hernandez, Adrian
    Koglin, Joerg
    Lam, Carolyn
    O'Connor, Christopher
    Pieske, Burkert
    Ponikowski, Piotr
    Roessig, Lothar
    Voors, Adriaan
    Anstrom, Kevin
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 141 - 141
  • [26] Vericiguat: A Review in Chronic Heart Failure with Reduced Ejection Fraction
    Kang, Connie
    Lamb, Yvette N.
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2022, 22 (04) : 451 - 459
  • [27] Evaluating haemodynamic changes: vericiguat in patients with heart failure with reduced ejection fraction
    Suzuki, Hideaki
    Inoue, Takumi
    Terui, Yousuke
    Takeuchi, Kouki
    Susukita, Kai
    Arai, Marina
    Sato, Haruka
    Satoh, Taijyu
    Yamamoto, Saori
    Yaoita, Nobuhiro
    Tatebe, Shunsuke
    Hayashi, Hideka
    Nochioka, Kotaro
    Takahama, Hiroyuki
    Yasuda, Satoshi
    [J]. ESC HEART FAILURE, 2024, 11 (04): : 2451 - 2454
  • [28] Population Pharmacokinetics and Pharmacodynamics of Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
    Hauke Ruehs
    Dagmar Klein
    Matthias Frei
    Joachim Grevel
    Rupert Austin
    Corina Becker
    Lothar Roessig
    Burkert Pieske
    Dirk Garmann
    Michaela Meyer
    [J]. Clinical Pharmacokinetics, 2021, 60 : 1407 - 1421
  • [29] Vericiguat: A Review in Chronic Heart Failure with Reduced Ejection Fraction
    Connie Kang
    Yvette N. Lamb
    [J]. American Journal of Cardiovascular Drugs, 2022, 22 : 451 - 459
  • [30] Cost Effectiveness of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event from a US Medicare Perspective
    Adnan Alsumali
    Laurence M Djatche
    Andrew Briggs
    Rongzhe Liu
    Ibrahim Diakite
    Dipen Patel
    Yufei Wang
    Dominik Lautsch
    [J]. PharmacoEconomics, 2021, 39 : 1343 - 1354
12345